Trends in Molecular Medicine
ReviewTRPV1: a therapeutic target for novel analgesic drugs?
Section snippets
The transient receptor potential vanilloid subfamily member 1, TRPV1
It is an exciting time in pain research. The past ten years have seen the emergence of specific small molecule antagonists targeting receptors on sensory neurons that detect painful stimuli. Among these new therapeutic targets, TRPV1 has attracted the most attention [1]. TRPV1 (formerly known as the vanilloid receptor VR1) is probably still best recognized as the receptor for capsaicin, which is responsible for the piquancy of hot chili peppers [2]. Capsaicin is unique among naturally occurring
TRPV1 and its family
Ironically, the founding member of the TRPV vanilloid receptor subfamily TRPV1 remains the only vanilloid receptor that is a target for capsaicin and other vanilloids. Up to date, the TRPV subfamily has six members, TRPV1–TRPV6. TRPV5 and TRPV6 seem to be constitutively active and are thought to have a role in vitamin D-dependent Ca2+ uptake in the kidney and intestine, respectively 8, 9. TRPV4 was originally identified as an osmotic receptor detecting decreased osmolarity [10]. Interestingly,
The broad tissue distribution of TRPV1 and its implications for therapy and side effects
Functional TRPV1 is expressed both in the brain (from the olfactory bulb to the cortex and from the basal ganglia to the cerebellum) [17] and in various non-neuronal tissues. From a pharmacological point of view, this phenomenon might be considered as a double-edged sword: TRPV1 in these tissues might represent a novel therapeutic target and/or mediate unforeseen adverse effects. Either way, these findings place TRPV1 in a much broader context than simply a polymodal pain sensor on primary
TRPV1 is regulated at multiple levels providing opportunities for pharmacological intervention
TRPV1 is now recognized as a molecular integrator of various noxious stimuli, both physical (noxious heat) and chemical (e.g. capsaicin analogs, protons and lipid derivative endovanilloids) (Figure 1). This last group of molecules includes diverse agents such as cannabimimetic lipids (e.g. anandamide 19, 20, 35, N-arachidonoyl dopamine [36] and other endogenous unsaturated C18 N-acetylethanolamines [37]), eicosanoid precursors (e.g. 12- and 5-hydroperoxy-eicosatetraeonic acids) [38] and the
Disease-specific regulation of TRPV1
Disease-related changes in TRPV1 expression are bi-directional. As discussed earlier, increased TRPV1-immunoreactive fiber innervation was demonstrated in inflamed human skin [56], vulva [55] and gastrointestinal tract [54], in addition to tooth pulp with caries [57]. This increase in TRPV1 expression was suggested to contribute to the pathogenesis of various disease states (e.g. reflux esophagitis, inflammatory bowel disease, irritable bowel syndrome, vulvar allodynia and prurigo nodularis),
TRPV1 in bladder disorders
From a theoretical point of view, TRPV1 antagonists are of special interest in bladder disorders because TRPV1, whether overexpressed or not, might be activated by endogenous ligands that can accumulate in the diseased tissue (Figure 2). Therefore, the most-obvious clinical application for TRPV1 antagonists is in the treatment of pain and bladder hyperactivity that accompanies interstitial cystitis, a chronic inflammatory condition of the bladder of unknown etiology. This notion has gained
Migraine and other types of pain or inflammatory conditions
The ability to reduce thermal, but more importantly mechanical, hyperalgesia is a paramount feature of analgesic compounds. Studies in TRPV1-deficient mice clearly showed the role of TRPV1 in thermal, but not mechanical, hyperalgesia 6, 7. The old-generation antagonist capsazepine confirmed this anti-hyperalgesic profile in the rat but, surprisingly, it reduced also mechanical hyperalgesia in the guinea pig [77]. Recently developed antagonists associated the ability to inhibit thermal and
TRPV1-deficient mice predict adverse effects for antagonist
Generally, TRPV1-deficient mice have a benign phenotype, including altered bladder function (high-frequency non-voiding contractions) [25]. Recent findings, however, indicate that such animals might fare much worse than their wild-type littermates under pathological conditions such as post-ischemic recovery of the heart [83]. The well-known French Paradox – that is the protective action of alcoholic beverages on coronary artery disease – might be in part explained with the recent finding that
Future directions
The TRPV1 literature is vast and suffers from many unconfirmed and/or conflicting results. For example, recently both the presence [89] and absence [90] of TRPV1 in mouse dendritic cells have been reported. Such discrepant results need to be resolved. The function of TRPV1 in physiological functions remains poorly understood. There is a clear gap between the unremarkable phenotype of TRPV1-deficient mice and the broad interference of TRPV1 antagonists with physiological functions, ranging from
Concluding remarks
Endovanilloids that act on TRPV1, which is a molecular integrator of noxious stimuli, are believed to have a pivotal role in certain pain conditions. Indeed, desensitization of TRPV1 to the agonist capsaicin and RTX is a powerful approach to relieve inflammatory, post-operative and chronic neuropathic pain [2]. TRPV1 agonists, however, are doing much more than simply desensitizing TRPV1: they render the whole neuron unresponsive to a large series of stimuli unrelated to TRPV1 [2]. Mechanisms
Acknowledgements
We thank Marcello Trevisani for preparing the figures. Furthermore, we apologize to those authors whose work could not be cited owing to length restrictions.
References (104)
TRP ion channels in the nervous system
Curr. Opin. Neurobiol.
(2004)Peripheral inflammation induced up-regulation of TRPV2 expression in rat DRG
Pain
(2005)Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in mouse brain
Neuroscience
(2006)- et al.
Lipids as regulators of the activity of transient receptor potential type 1 (TRPV1) channels
Life Sci.
(2005) Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis
Neurobiol. Dis.
(2005)Functional vanilloid receptors in cultured normal human epidermal keratinocytes
Biochem. Biophys. Res. Commun.
(2002)A hot new twist to hair biology: involvement of vanilloid receptor-1 (VR1/TRPV1) signaling in human hair growth control
Am. J. Pathol.
(2005)- et al.
Topical capsaicin in pruritic psoriasis
J. Am. Acad. Dermatol.
(1994) Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder
Eur. Urol.
(2005)Arachidonoyl ethanolamide induced apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1
Gynecol. Oncol.
(2004)
Vanilloid receptor activation by 2- and 10 micrometer particles induces responses leading to apoptosis in human airway epithelial cells
Toxicol. Appl. Pharmacol.
TRP channels and medulation by hepatocyte growth factor/scatter factor in human hepatoblastoma (HepG2) cells
Cell Calcium
Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors
Brain Res. Mol. Brain Res.
Inflammatory mediators convert anandamide into a potent activator of the vanilloid type 1 transient receptor potential receptor in nociceptive primary sensory neurons
Neuroscience
Endogenous unsaturated C18 N-acylethanolamines are vanilloid receptor (TRPV1) agonists
J. Biol. Chem.
Activation of TRPV1 by the satiety factor oleoylethanolamide
J. Biol. Chem.
Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity
J. Biol. Chem.
Regulation of Ca2+-dependent desensitization in the vanilloid receptor TRPV1 by calcineurin and cAMP-dependent protein kinase
J. Biol. Chem.
Increased sensitivity of desensitized TRPV1 by PMA occurs through PKCɛ-mediated phosphorylation at S800
Pain
cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation
Neuron
Phosphorylation of vanilloid receptor 1 by Ca2+/calmodulin-dependent kinase II regulates its vanilloid binding
J. Biol. Chem.
Vanilloid receptor 1 immunoreactivity in inflamed human bowel
Lancet
increased vanilloid receptor VR1 innervation of vulvodynia
Eur. J. Pain
Regulation of calcitonin gene-related peptide and TRPV1 in a rat model of osteoarthritis
Neurosci. Lett.
Medium and large injured dorsal root ganglion cells increase TRPV1, accompanied by increased α2C-adrenoceptor co-expression and functional inhibition by clonidine
Pain
Early painful diabetic neuropathy is associated with differential changes in the expression and function of vanilloid receptor 1
J. Biol. Chem.
Investigation of the role of TRPV1 receptors in acute and chronic nociceptive processes using gene-deficient mice
Pain
Protein kinase C contributes to abnormal capsaicin responses in DRG neurons from cats with feline interstitial cystitis
Neurosci. Lett.
Peptidergic sensory and parasympathetic fiber sprouting in the mucosa of the rat urinary bladder in a chronic model of cyclophosphamide-induced cystitis
Neuroscience
Intravesical infusion of resiniferatoxin by a temporary in situ drug delivery system to treat interstitial cystitis: a pilot study
Eur. Urol.
Intravesical resiniferatoxin for the treatment of interstitial cystitis : a randomized, double-blind, placebo controlled trial
J. Urol.
Mechanism involved in new therapies for overactive bladder
Urology
P2X3-immunoreactive nerve fibers in neurogenic dtrusor overactivity and the effect of intravesical resiniferatoxin
Eur. Urol.
Repeated intranasal capsaicin applications to treat chronic migraine
Br. J. Anaesth.
Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency
Lancet
Dendritic cells do not transduce inflammatory stimuli via the capsaicin receptor TRPV1
FEBS Lett.
Attenuated fever response in mice lacking TRPV1
Neurosci. Lett.
Effects of TRPV1 receptor antagonists on stimulated iCGRP release from isolated skin of rats and TRPV1 mutant mice
Pain
The anandamide transport inhibitor AM404 activates vanilloid receptors
Eur. J. Pharmacol.
Transient receptor potential ion channels as targets for the discovery of pain therapeutics
Curr. Opin. Investig. Drugs
Vanilloid (capsaicin) receptors and mechanisms
Pharmacol. Rev.
The influence of local capsaicin treatment on small nerve fiber function and neurovascular control in symptomatic diabetic neuropathy
Acta Diabetol.
The capsaicin receptor: a heat-activated ion channel in the pain pathway
Nature
Impaired nociception and pain sensation in mice lacking the capsaicin receptor
Science
Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia
Nature
The epithelial calcium channels TRPV5 and TRPV6: regulation and implications for disease
Naunyn Schmiedebergs Arch. Pharmacol.
The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells
Mol. Endocrinol.
Mammalian TRPV4 (VR-OAC) directs behavioral responses to osmotic and mechanical stimuli in Caenorhabditis elegans
Proc. Natl. Acad. Sci. U. S. A.
A transient receptor potential vanilloid 4-dependent mechanism of hyperalgesia is engaged by concerted action of inflammatory mediators
J. Neurosci.
A heat-sensitive TRP channel expressed in keratinocytes
Science
Cited by (165)
The role of TRP ion channels in migraine and headache
2022, Neuroscience LettersCurrent View of Ligand and Lipid Recognition by the Menthol Receptor TRPM8
2020, Trends in Biochemical SciencesCapsaicin produces antidepressant-like effects in the forced swimming test and enhances the response of a sub-effective dose of amitriptyline in rats
2018, Physiology and BehaviorCitation Excerpt :This has stimulated the search for new therapies, among which the modulation of transient receptor potential vanilloid type 1 (TRPV1) channels may represent a novel strategy in the treatment for depression. Initially, TRPV1 was only associated with pain and temperature sensing [16,44]. However, TRPV1 channels have been found in nearly all areas of the brain, especially in structures of the limbic system, suggesting additional functions for these channels [29].
2-Methylacrylamide as a bioisoster of thiourea group for 1,3-dibenzylthioureido TRPV1 receptor antagonists
2018, Bioorganic and Medicinal Chemistry LettersPolymodal Transient Receptor Potential Vanilloid Type 1 Nocisensor: Structure, Modulators, and Therapeutic Applications
2016, Advances in Protein Chemistry and Structural BiologyA Systematic Investigation of Thermal Effects of High-Intensity Focused Ultrasound Therapy for Ultrasound Neuromodulation
2024, IEEE Transactions on Instrumentation and Measurement